Oncology Research and Treatment

Papers
(The TQCC of Oncology Research and Treatment is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study26
Follow-up time of anal cancer screening among women living with HIV at high risk of developing anal cancer25
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 202325
PharmaNews24
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience24
Polypharmazie - Wechselwirkungen der BTKi21
uGI: Biomaker-Cut-Offs in der Immunonkologie20
PharmaNews18
Front & Back Matter18
Front & Back Matter16
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab16
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis13
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis13
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors13
Society Bulletins13
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease12
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy11
Society Bulletins11
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer – What Tools Do We Have to Make the Right Decision?9
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice8
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center8
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial8
Body Composition and Inflammation as emerging Sex-specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma undergoing Immune Checkpoint-Inhibition Therapy – a Prospective Pilot Study8
Society Bulletins7
PharmaNews7
Career and Professional Development for Young Oncologists7
Front & Back Matter7
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem7
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine7
OnkoImmun 217
Front & Back Matter6
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany6
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors6
PharmaNews6
PharmaNews6
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer6
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 756
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz6
Front & Back Matter6
DKK 2024: Acalabrutinib im Praxis-Check6
Erratum5
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial5
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients5
Vorwort des DGHO-Vorstands5
Management of Advanced Penile Cancer5
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report5
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology5
Society Bulletins5
NSCLC: RWE-Daten zur Sequenztherapie5
Epcoritamab: Indikationserweiterung für das FL5
Capivasertib/Fulvestrant bei ER+/HER2– MBC5
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative5
PharmaNews5
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer5
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM4
Therapiemanagement von Sacituzumab Govitecan4
Durvalumab auch bei Hirnmetastasen vorteilhaft4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality4
Oncology in Europe4
Das inoperable NSCLC im Stadium III im Dialog4
A current assessment of the use of complementary medicine in German cancer patients - the CONKO 022 investigation4
PharmaNews4
Society Bulletins4
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi4
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models4
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report4
PharmaNews4
Prelims4
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL4
Psychological stress in breast cancer patients during the course of a pandemic disease – before and after the availability of vaccines4
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%3
Perspectives for Cancer Care and Research in Central and Eastern Europe3
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie3
Risk and Prognosis of Subsequent Primary Gastric Cancer3
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein3
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy3
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen3
Erratum3
Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer3
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin3
PharmaNews2
Society Bulletins2
Society Bulletins2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20232
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers2
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey2
Society Bulletins2
PharmaNews2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment2
A Randomized, Controlled Pilot Study to Evaluate the Immediate Effect of Targeted Exercise Therapy on Cancer-Related Fatigue in Cancer Survivors: The FatiGO Study2
PharmaNews2
PharmaNews2
Front & Back Matter2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich2
Prelims2
Front & Back Matter2
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study2
Guidelines of Onkopedia: What Is New?2
Society Bulletins2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study2
PharmaNews2
Society Bulletins2
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie2
Nintedanib und Docetaxel beim Adenokarzinom der Lunge2
Nivolumab plus Ipilimumab beim metastasierten Melanom2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy2
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines2
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review2
OnkoImmun 192
Management of Patients Undergoing CAR-T Cell Therapy in Germany2
Recent Advances in Castleman Disease2
Erweiterte Therapieoptionen bei EGFRm NSCLC2
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma1
Onkologische Patient*innen individuell behandeln und begleiten1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies1
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel1
PharmaNews1
Acknowledgement to Reviewers1
Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment1
Prelims1
Prognostic Significance of HER2 Positivity in Endometrium Cancer1
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review1
PharmaNews1
Society Bulletins1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast1
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis1
Front & Back Matter1
Adverse effects and functional outcome after salvage lymph node dissection in prostate cancer1
Front & Back Matter1
Contents Vol. 47, 20241
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database1
Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–20181
Society Bulletins1
ALL - Blinatumomab verbesserte die Prognose für Kinder1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres1
Ovarian Cancer and Its Association with Endometriosis: A Narrative Review1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis1
Society Bulletins1
OnkoImmun 181
Front & Back Matter1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries1
0.29604983329773